We are live on ! Find out more
CLVS

Clovis Oncology, Inc.
CLVS

Delisted

CLVS was delisted on the 20th of December, 2022.

Back to rankings

186 hedge funds and large institutions have $1.24B invested in Clovis Oncology, Inc. in 2019 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 62 increasing their positions, 49 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 18

30% more capital invested

Capital invested by funds: $953M → $1.24B (+$285M)

27% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 49

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

21% more call options, than puts

Call options by funds: $50.7M | Put options by funds: $41.8M

13% more funds holding

Funds holding: 165 → 186 (+21)

Holders
186
Holders Change
+21
Holders Change %
+12.73%
% of All Funds
4.03%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
40
Increased
62
Reduced
49
Closed
18
Calls
$50.7M
Puts
$41.8M
Net Calls
+$8.91M
Net Calls Change
-$15.7M

Top Buyers

Rank Fund Capital Flow
1
HM
HealthCor Management
New York
+$35.1M
2
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$20.2M
3
RG
Redmile Group
California
+$12.6M
4
CS
Candriam SCA
Luxembourg
+$12.2M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$11.5M

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$73.6M
2
CCM
Camber Capital Management
Massachusetts
-$32.6M
3
PC
PointState Capital
New York
-$18.7M
4
SC
Samlyn Capital
New York
-$15.9M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$15.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
WCM
126
Weld Capital Management
New York
$297K +$300K +11,957 New
TI
127
Trexquant Investment
Connecticut
$274K +$277K +11,031 New
MSU
128
Mizuho Securities USA
New York
$261K +$263K +10,500 New
XK
129
Xact Kapitalforvaltning
Sweden
$224K +$226K +9,030 New
Commonwealth Equity Services
130
Commonwealth Equity Services
Massachusetts
$221K +$224K +8,918 New
US Bancorp
131
US Bancorp
Minnesota
$219K +$17.1K +681 +8%
VF
132
Virtu Financial
New York
$215K +$217K +8,669 New
USAA
133
United Services Automobile Association
Texas
$215K +$218K +8,681 New
Wolverine Trading
134
Wolverine Trading
Illinois
$211K -$639K -25,495 -75%
SL
135
Signition LP
New York
$210K +$212K +8,470 New
HighTower Advisors
136
HighTower Advisors
Illinois
$207K +$210K +8,375 New
CCA
137
Conservest Capital Advisors
Pennsylvania
$206K -$254K -10,116 -55%
CAL
138
Capital Analysts LLC
Pennsylvania
$201K +$185K +7,375 +983%
Verition Fund Management
139
Verition Fund Management
Connecticut
$200K +$202K +8,070 New
AWM
140
Avior Wealth Management
Nebraska
$192K +$194K +7,740 New
Public Employees Retirement Association of Colorado
141
Public Employees Retirement Association of Colorado
Colorado
$188K – – –
Canada Life
142
Canada Life
Manitoba, Canada
$174K – – –
SAM
143
Shell Asset Management
Netherlands
$163K – – –
Bank of Montreal
144
Bank of Montreal
Ontario, Canada
$153K -$31.2K -1,243 -17%
SEI Investments
145
SEI Investments
Pennsylvania
$144K -$32.9K -1,314 -18%
AIP
146
Ameritas Investment Partners
Nebraska
$98K – – –
AAM
147
Advisors Asset Management
Colorado
$82K -$28.3K -1,128 -25%
LTFS
148
Ladenburg Thalmann Financial Services
Florida
$77K +$38.1K +1,519 +93%
Zurich Cantonal Bank
149
Zurich Cantonal Bank
Switzerland
$68K -$9.78K -390 -12%
PIA
150
Phoenix Investment Adviser
New York
$62K +$62.7K +2,500 New
4 5
6
7 8

CLVS Hedge Fund Activity: Q1 2019 in Review

186 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Clovis Oncology, Inc. (CLVS) for Q1 2019, worth a combined $1.24B — up 30% from $953M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new CLVS positions and 18 closed out — a net gain of 22 holders — while 62 added to existing stakes and 49 trimmed.

The largest buyer was HealthCor Management, opening a new position worth an estimated $35.1M. The largest seller was Armistice Capital, cutting an estimated $73.6M.

  • 186 institutional investors held Clovis Oncology, Inc. (CLVS) as of Q1 2019, up from 165 in Q4 2018.
  • Funds reported $1.24B of Clovis Oncology, Inc. stock for Q1 2019, up 30% quarter-over-quarter.
  • 40 funds opened new Clovis Oncology, Inc. positions in Q1 2019 and 18 closed out, a net change of +22 holders.
  • The largest Clovis Oncology, Inc. buyer in Q1 2019 was HealthCor Management, an estimated $35.1M added.
  • The largest Clovis Oncology, Inc. seller in Q1 2019 was Armistice Capital, an estimated $73.6M sold.

Based on aggregated 13F filings for Q1 2019.